Female Urology

Latest News

Vaginal estrogen improves vaginal atrophy, has no effect on pelvic organ prolapse recurrence
Vaginal estrogen improves vaginal atrophy, has no effect on pelvic organ prolapse recurrence

August 17th 2023

The incidence of 12-month surgical repair failure was 19% among those who received vaginal estrogen, compared with 9% among those who received placebo.

FDA grants priority review to cefepime-taniborbactam for complicated UTIs
FDA grants priority review to cefepime-taniborbactam for complicated UTIs

August 15th 2023

Free Webinar: Urinary Incontinence Essentials for Primary Care
Free Webinar: Urinary Incontinence Essentials for Primary Care

July 31st 2023

Protein biomarkers associated with cellular aging may be predictive of pelvic organ prolapse risk
Protein biomarkers associated with cellular aging may be predictive of pelvic organ prolapse risk

July 7th 2023

Vaginal administration of Lactobacilli may prevent recurrent cystitis in postmenopausal women
Vaginal administration of Lactobacilli may prevent recurrent cystitis in postmenopausal women

July 6th 2023

Latest CME Events & Activities

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

View More

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

5th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Register Now!

Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

23rd Annual International Congress on the Future of Breast Cancer® East

Register Now!

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

4th Annual International Congress on the Future of Women’s Health™

View More

© 2023 MJH Life Sciences

All rights reserved.